The Adult Medicine PRN would like to recognize and congratulate the following members on their notable accomplishments:

Suzanne B. Wortman was honored with the 2010–2011 APPE Institutional Preceptor of Year by Lake Erie College of Medicine.

Nancy Toedter Williams was honored as a fellow of the American Society of Health-System Pharmacists during the society’s summer meeting in Denver.

Beth Resmen-Targoff was named the 2011 Oklahoma Society of Health-System Pharmacists Pharmacist of the Year.

Scot Walker was named Head of Facts & Comparisons as the Clinical Director. Previously responsible for the clinical team, formulary monograph service, and patient education used in Medi-Span and Facts & Comparison, he now leads all editorial and content staff.

Publications:

O’Connell MB, Borgelt LM, Bowles SK, Vondracek SF. Drug-induced osteoporosis in the older adult. Aging Health 2010;10:501–18.

Colon-Emeric C, O’Connell MB, Haney E. The osteoporosis piece of the multi-morbidity puzzle. Mt Sinai Med J 2011;78:515–26.

Chotiyaputta W, Peterson C, Ditah FA, Goodwin D, Lok AS. Persistence and adherence to nucleos(t)ide analogue treatment for chronic hepatitis B. J Hepatol 2011;54:12–8.

Hu KQ, Pan CQ, Goodwin D. Barriers to screening for hepatitis B virus infection in Asian Americans. Dig Dis Sci 2011; Aug 23. [Epub ahead of print]

Presentations:
Beth Resmen-Targoff provided three interviews this year for a podcast series titled “From Principle to Practice: Interprofessional Perspectives on Early RA. What Do the Updated RA Classification Criteria Mean for You?” This is a CME/CE-accredited activity through the Center for Independent Healthcare Education.

The Ambulatory Care PRN continues to thrive with a membership of more than 1,300 members. Some notable achievements of individuals from the Ambulatory Care membership during the past year are noted below.

Promotions:
Candice Garwood was promoted to Associate Professor (Clinical) at Eugene Applebaum College of Pharmacy and Health Sciences at Wayne State University.
Jennifer Goldman-Levine was promoted to Professor of Pharmacy Practice at Massachusetts College of Pharmacy and Health Sciences.

Sally Haack was promoted to Associate Professor of Clinical Sciences at Drake University.

Sarah Westberg was promoted to Associate Professor at the University of Minnesota College of Pharmacy.

Awards:

Nicole Culhane and a colleague won the 2011 Maryland HealthCare Hero Award for the Community Outreach Category for a Public Health Initiative called AdvoCaring.

Daniel M. Riche won the ACCP New Clinical Practitioner of the Year Award for 2011.

Betsy Blake was awarded the Clinical Practice Teaching Award from the University of South Carolina this past spring. This was the first year for the award, which is the first nontenure-track teaching award for faculty at USC.

Julie Bartell was selected for the Young Pharmacist of the Year Award from the Pharmacy Society of Wisconsin.

Grants:
Peggy Kuehl is Director for the UMKC Community Residency Program, which was awarded one of three Community Pharmacy Residency Program grants of $50,000 from the NACDS Foundation for the Red Cross Pharmacy location.

Publications:

M. Shawn McFarland:
Cripps RJ, Gourley ES, Johnson W, Cassidy R, Morgan TC, Venugopal D, McFarland MS. An evaluation of diabetes-related measures of control after 6 months of clinical pharmacy specialist intervention. J Pharm Pract 2011;24:332–8.
McFarland MS, Brock M, Ryals C. Place in therapy for liraglutide and saxagliptin for type 2 diabetes. South Med J 2011;104:426–39.

Eric Jackson:
Trojian TH, Jackson E. Omega-3 polyunsaturated fatty acids and concussions: treatment or not? Curr Sports Med Rep 2011;10:180–5.

Martha Stassinos:
Publication: Women’s Health Across the Lifespan. A Pharmacotherapeutic Approach. Bethesda, MD: American Society of Health-System Pharmacists, 2010. Cowrote chapter on obesity
PSAP Module on Men’s and Women’s Health 2010. Expert reviewer.

Craig Williams:
Pignone M, Williams CD. Aspirin for primary prevention of cardiovascular disease in diabetes mellitus. Nat Rev Endocrinol 2010;6:619–28.

Kassandra Bartelme:
Bartelme KM, Ticcioni AJ, Janke KK. Providing health care service-learning experiences for IPPE credit. Innov Pharm 2011;3:1–5.

Robert Hutchison:
Hutchison RW, Govathoti DA, Fehlis K, et al. Improving severe sepsis outcomes. Dimen Crit Care Nurs 2011;30:277–82.

Andrew J. Smith:
Patterson ME, Blalock SJ, Smith AJ, Murray MD. Associations between prescription copayment levels and beta-blocker medication adherence in commercially insured heart failure patients. Clin Ther 2011;33:608–16.
Roberts S, Crigler J, Lafferty W, Bonham A, Hunter J, Smith AJ, Banderas J, Early G, King R. Addressing social determinants to improve health care quality and reduce cost. J Healthc Qual. In press.

New ACCP Fellows:

Brian Irons, Pharm.D.; Lubbock, TX
Grace Kuo, Pharm.D., MPH; La Jolla, CA
Leigh Ann Ross, Pharm.D.; Jackson, MS

Other Notable Achievements:

Martha Stassinos was appointed to represent pharmacy on the Women Veterans Health Care Committee for the Veterans Administration of Northern California in August 2011. In addition, she was awarded 0.2 FTEs to serve as Women’s Health Consultant to Providers throughout the Veterans Administration of Northern California.

Steven M. Riddle was elected ASHP Chair for the Section of Ambulatory Care Practitioners.

Andrew J. Smith earned Added Qualifications in Cardiology.

Scot Walker became Head of Facts & Comparisons. He was previously responsible for the clinical team for Facts & Comparisons, formulary monograph service, and patient education used in Facts & Comparisons and Medi-Span. He is now leading all editorial and content staff.

Maria M. Claudio presented a lecture to the Greater New York Hospital Association on the success of the pharmacy-managed heart failure clinics she implemented on reducing the rates of CHF-related readmissions.

Caption Study:

Barry Carter is the principal investigator on a large, multicenter study titled “Collaboration Among Pharmacists Physicians to Improve Outcomes Now” (CAPTION). The purpose of this study is to evaluate whether a collaborative model between physicians and pharmacists can improve BP control in several primary care medical offices with diverse geographic and patient characteristics and whether long-term BP control can be sustained. A description of the study was published in Circulation: Cardiovascular Quality and Outcomes in 2010, volume 3, pages 418–23. The following PRN members are serving as site investigators for this 27-site study:

Adrienne Ables
Julie Adkison
Oralia Bazaldua
Lori Dickerson
Rebecca Edwards
Roberta Farrah
Jennifer Goldman-Levine
James Hoehns
John Holmes
Timothy Ives
Eric Jackson
Mark Jones
Grace Kuo
Debra Lopez
Eric MacLaughlin
Elizabeth Musil
Margie Perez-Padilla
Kelly Ragucci
Sarah Shrader
Jeri Sias
Renu Sing
John Tovar
CoraLynn Trewet

Ambulatory Care Seed Grant Research Report:

Laura Perry was the recipient of the ACCP Ambulatory Care PRN Seed Grant in 2010. Below is an abstract describing her research and preliminary results.

The Impact of a Pharmacist-Run Diabetes Self-Management Program on Patient Self-Management Activation and Healthy Behavior in an Underserved Patient Population
Laura Perry, Pharm.D., BCPS, Tonya Dauterman, Pharm.D., Lori Ernsthausen, Pharm.D., BCPS, Debra Parker, Pharm.D., BCPS; Jenifer Kitchen, Tom Kahle, Peter Samberg, Brett Christy, Pharm.D. Candidates

Background: The Wood County Health Department (WCHD) in Bowling Green, Ohio, has recently established a pharmacist-physician diabetes collaborative practice clinic as a part of the Patient Safety and Clinical Pharmacy Services Collaborative (PSPC), a program developed by the Health Resources and Services Administration (HRSA) division of the U.S. Department of Health and Human Services. Currently, the WCHD is the only clinic in the area providing services to the uninsured and the facility lacks a standardized diabetic education program. Additionally, few studies have been published assessing patient activation or stages of change in diabetes patients. The aim of this project is to investigate the impact of a pharmacist-run diabetes self-management training program on patient activation, behavior, and glycemic control.

Methods: Enrollment was through referral by the nurse practitioner at the WCHD. The program included four monthly pharmacist-run diabetes self-management educational sessions, free of expense. Each session consisted of a didactic lecture and an active learning break out in the form of a support group. The curriculum was designed to meet the standards set by the American Association of Diabetic Educators (AADE) and the AADE7 Self-Care Behaviors framework (healthy eating, physical activity, medication taking, monitoring, problem-solving, healthy coping, and reducing risks). After the four monthly sessions, a follow-up support group will be held at six months, followed by an observational period and final support at 12 months. The primary outcome of the investigation is the Patient Activation Measure (PAM), a reliable and valid measure of patient self-reported knowledge, skill, and confidence for self-management. Secondary endpoints will be change in healthy behavior, change in HbA1c, and patient satisfaction. Primary and secondary end points have been measured at baseline and will be measured again at six and 12 months.

Preliminary Results/Conclusions: A total of 21 patients were enrolled. Of the patients enrolled 16 had never had any formal diabetic education. Baseline demographics indicate patients enrolled have had diabetes for an average of 8.5 years with an average hemoglobin A1C of 7.0 %. At baseline, 46.7% of patients were at the highest level of activation, indicating they have the knowledge and confidence to take action, but that they have difficulty maintaining activation, while only 14.3% of patients scored at the lowest level of activation, indicating they may not yet believe that they have an important role in their diabetes care. Collection and analysis of six month data is currently taking place. Final data collection and full analysis of primary and secondary endpoints will be completed in February, 2012.

The Cardiology PRN is pleased to announce the following upcoming collaborative symposia for 2011:
Cardiology PRN and American Heart Association Focus Session—The “Me” Generation of Healthcare: Personalized Medicine in Cardiovascular Disease
Annual ACCP Meeting, Pittsburgh, PA. Monday, October 17, 2011, from 1:30 p.m. to 3:30 p.m. For more details, please visit: www.accp.com/meetings/am11/schedule.aspx?mode=detail&i=2034
First Pharmacist-Focused Session at AHA. ACCP Cardiology PRN and American Heart Association – Improving Clinical Outcomes and Patient Safety Through Interventions by Clinical Pharmacists. AHA Scientific Sessions, Orlando, FL. Sunday, November 13, 2011, from 5:30 p.m. to 6:45 p.m. For more details, please visit: http://formularyjournal.modernmedicine.com/formulary/Clinical+News/First-pharmacist-focused-session-coming-to-AHA-Sci/ArticleStandard/Article/detail/734013

Cardiology PRN Award Recipients:

New Student Travel Award – Tiffany Sanders (University of Oklahoma)
New Resident/Fellow Travel Awards – Adam Bress (University of Illinois at Chicago) and Przemyslaw Radwanski (University of Utah)
Mentoring Award – Toni Ripley (University of Oklahoma)
Junior Investigator Award – Craig Lee (University of North Carolina)
Best Paper Award – Rhonda Cooper-DeHoff (University of Florida)
The Cardiology PRN Seed Research Grant Award winner will be announced before the ACCP Annual Meeting; the recipient will receive a $5,000 stipend toward his or her research project.

Individual Member Accomplishments

Awards, Academic Appointments and Promotions, and Leadership:
Sheryl Chow, Shannon Finks, Craig Lee, Kari Olson, Brian Overholser, Kerry Pickworth, and Amy Seybert will be inducted as fellows of the American College of Clinical Pharmacy (FCCPs).
Julie Bartell received the Young Pharmacist of the Year Award from the Pharmacy Society of Wisconsin.
Judy Cheng received the Teacher of the Year (Pharmacy Practice) Award and the Faculty Service Award at the Massachusetts College of Pharmacy and Health Sciences.
Richard Fleck was named Head of Clinical Pharmacology for the GlaxoSmithKline Metabolic Pathways and Cardiovascular Therapeutic Area Unit.
Michael Gillette received a travel award from the American College of Cardiology for the Legislative Conference, and he was elected to the ASHP Clinical Specialists and Scientists Advisory Group as well as to the Resident Advisory Committee for ACCP as Vice Chair.
Tracy Macaulay was awarded the Outstanding Faculty Member Award by the 2012 class at the University of Kentucky College of Pharmacy.
Michael Nash and Barbara Wiggins were inducted as Associates of the American College of Cardiology (AACC).
Carrie Oliphant was promoted to Associate Professor of Pharmacy at the University of Tennessee College of Pharmacy.
Kelly Rogers was promoted to Professor of Clinical Pharmacy at the University of Tennessee College of Pharmacy.
Jim Tisdale was inducted as a fellow of the American Heart Association (FAHA).
Toby Trujillo served as Co-chair for the Summer Conference on Cardiology for the Society of Critical Care Medicine (SCCM).
Orly Vardeny was promoted to Associate Professor of Pharmacy, Pharmacy Practice Division, University of Wisconsin School of Pharmacy.
Jim Hollands, Carrie Oliphant, and Andrew Smith received Added Qualifications in Cardiology from the Board of Pharmacy Specialties this year.

Publications (limited to three):

Chen WT, White CM, Phung OJ, Kluger J, Ashaye A, Sobieraj D, Makanji S, Tongbram V, Baker WL, Coleman CI. Association between CHADS2 risk factors and anticoagulation-related bleeding: a systematic literature review. Mayo Clin Proc 2011;86:509–21.

Chen WT, White CM, Phung OJ, Kluger J, Ashaye A, Sobieraj D, Makanji S, Tongbram V, Baker WL, Coleman CI Are the risk factors listed in warfarin prescribing information associated with anticoagulation-related bleeding? A systematic literature review. Int J Clin Pract 2011;65:749–63.

Colby JA, Chen WT, Baker WL, Coleman CI, Reinhart KM, Kluger J, White CM. Effect of ascorbic acid on inflammatory markers after cardiothoracic surgery. Am J Health Syst Pharm 2011;68:1632–9.

Runyan CL, Cabral KP, Riker RR, et al. Correlation of bivalirudin dose during treatment of heparin-induced thrombocytopenia. Pharmacotherapy 2011;31:850–6.

Patterson ME, Blalock SJ, Smith AJ, Murray MD. Associations between prescription copayment levels and beta-blocker medication adherence in commercially insured heart failure patients. Clin Ther 2011;33:608–16.

Cheng JWM, Dopp AL, Kalus JL, Rogers KC, Sanoski CA, White CM. Key articles and guidelines in the management of arrhythmias, 2004-2010. Pharmacotherapy 2011;31:1e–32e.

Cheng JWM. Prevention and treatment of venous thromboembolic events: focus on dabigatran etexilate. Clin Med Insights Ther 2011;3:205–20.

Chow SL, O’Barr SA, Peng JT, Chew EE, Pak F, Patel P, Quist R, Patterson JH, Heywood JT. Modulation of novel cardiorenal and inflammatory biomarkers by intravenous nitroglycerin and nesiritide in acute decompensated heart failure: an exploratory study. Circ Heart Fail 2011;4:450–5.

Chow SL, Singh H, DiDomenico R, Dunn SP, Johnson SG, Marrs J, Vardeny O, Bleske BE. Key articles related to complementary and alternative medicine in cardiovascular disease. Part II. Pharmacotherapy 2011. In press. Available at www.pharmacotherapy.org/pdf/Key_Articles/Pharm3110e_Chow-CAM_pt2.pdf. Accessed September 23, 2011.

Dentali F, Marchesi C, Pierfranceschi MG, Crowther M, Garcia D, Hylek E, Witt DM, Clark NP, Squizzato A, Imberti D, Ageno W. Safety of prothrombin complex concentrates for rapid anticoagulation reversal of vitamin K antagonists. A meta-analysis. Thromb Haemost 2011;106:429–38.

Dentali F, Donadini MP, Clark N, Crowther MA, Garcia D, Hylek E, Witt DM, Ageno W; Warfarin Associated Research Projects and Other Endeavors (WARPED) Consortium. Brand name versus generic warfarin: a systematic review of the literature. Pharmacotherapy 2011;31:386–93.

Crouch MA, Colucci VJ, Howard PA, Spinler SA. P2Y12 receptor inhibitors: integrating ticagrelor into the management of acute coronary syndrome. Ann Pharmacother 2011;45:1151–6.

Crouch MA, ed. Securing and Excelling in a Pharmacy Residency. Sudbury, MA: Jones & Bartlett Learning, 2011.

Lachance K, Savoie M, Bernard M, Rochon S, Fafard J, Robitaille R, Vendittoli PA, Lévesque S, de Denus S. Ferrous sulphate does not increase preoperative haemoglobin in patients scheduled for hip or knee arthroplasty. Ann Pharmacother 2011;45:764–70.

Ensor CR, Russell SD, Wittstein IS, Conte JV. Capnocytophaga canimorsus sepsis in an asplenic heart transplant candidate with a left ventricular assist device. Prog Transplant 2011;21:121–3.

Finks SW, Rogers KC, Manguso AH. Assessment of sotalol prescribing in a community hospital: opportunities for clinical pharmacist involvement. Int J Pharm Pract 2011;19:281–6.

Deal EN, Hollands JM, Riney JN, Skrupky LP, Smith JR, Reichley RM. Therapeutic anticoagulation with enoxaparin and associated anti-Xa monitoring in patients with morbid obesity. J Thromb Thrombolysis 2011;32:188–94.

Miller AE, Montague D, Rodgers JE, Sanghvi S, Whinna HC, Krumnacher H. Substitution of a heparin correlation value for activated partial thromboplastin time in heparin nomograms. Am J Health Syst Pharm 2011;68:893–8.

Miller DF, Fortier CR, Garrison KL. Bar code medication administration technology: characterization of high-alert medication triggers and clinician workarounds. Ann Pharmacother 2011;45:162–8.

Price CA. Drug monographs. In: Schull PD, ed. Nurse’s Drug Handbook, 6th ed. New York: McGraw-Hill, 2011.

Price CA. Drug monographs. In: Karch AM, ed. Nursing Drug Guide. Philadelphia: Lippincott Williams & Wilkins, 2011, 2012.

Misky GJ, Manheim JC, Zehnder N, Nguyen V, Swenson PF, Klem P, Trujillo TC, Earnest MA. Health care disparities in the acute management of venous thromboembolism based on insurance status in the U.S. J Thromb Thrombolysis. 2011 Aug 30. [Epub ahead of print]

Rogers KC, Parker RB. Acute coronary syndrome: ST-elevation myocardial infarction. In: Schwinghammer TL, Koehler JM, eds. Pharmacotherapy Casebook: A Patient-Focused Approach, 8th ed. New York: McGraw-Hill, 2011:70–6.

Patterson ME, Blalock SJ, Smith AJ, Murray MD. Associations between prescription copayment levels and beta-blocker medication adherence in commercially insured heart failure patients. Clin Ther 2011;33:608–16.

Roberts S, Crigler J, Lafferty W, Bonham A, Hunter J, Smith AJ, Banderas J, Early G, King R. Addressing social determinants to improve health care quality and reduce cost. J Healthc Qual. In press.

Stacy ZA, Dobesh PP, Trujillo TC, Dager W, Ripley T, Olson KL. Key articles and guidelines in the management of peripheral arterial disease. Pharmacotherapy 2011;31:176e–206e.

Tisdale JE, Overholser BR, Wroblewski HA, Sowinski KM. The influence of progesterone alone and in combination with estradiol on ventricular action potential duration and triangulation in response to potassium channel inhibition. J Cardiovasc Electrophysiol 2011;22:325–31.

Fernando HC, Jaklitsch MT, Walsh GL, Tisdale JE, Bridges CD, Mitchell JD, Shrager JB. Society of Thoracic Surgeons practice guideline on the prophylaxis and management of atrial fibrillation following general thoracic surgery: executive summary. Ann Thorac Surg 2011. In press.

Tisdale JE, Overholser BR, Sowinski KM, Wroblewski HA, Amankwa K, Borzak S, Coram R, Kingery J, Zipes DM, Flockhart DA, Kovacs RJ. Enhanced sensitivity to drug-induced QT-interval lengthening in patients with heart failure due to left ventricular systolic dysfunction. J Clin Pharmacol 2011. In press.

Kiser TH, Mann AM, Trujillo TC, Hassell K. Evaluation of empiric versus nomogram-based direct thrombin inhibitor management in patients with suspected heparin-induced thrombocytopenia. Am J Hematol 2011;86:267–72.

Grants:

Sony Tuteja received a PPD Bioanalytical Fluid and Tissue Grant Award from the American College of Clinical Pharmacy for her project titled “Characterizing the Metabolic Pathway of Niacin.”

Sony Tuteja received a 2-year grant from the American Heart Association, Great Rivers Affiliate, for her project titled “Pharmacogenomics and Pharmacokinetics of Variation in Dermal and Metabolic Responses to Acute Niacin Administration.”

William Baker received a grant from Gilead Sciences, Inc, for $207,308 for a project titled “The Pharmacokinetics and Electrocardiographic Implications of Adjunctive Amiodarone and Ranolazine Therapy in Patients on Implantable Cardioverter Defibrillators: The Adjunctive Ventricular Arrhythmia Suppression Trial (AVAST) Pilot.”

Robert B. Parker received an NIH R15 grant for his project, Inhibition of Carboxylesterase Metabolism by Ethanol.

The Central Nervous System PRN consists of practitioners who work in the areas of neurology and psychiatry. We currently have 180 members.

Nominations Committee (Kelly Lee, Chair)
The Nominations Committee identifies and nominates deserving PRN members for ACCP fall and spring awards such as the Clinical Practice Award, Parker Medal, and New Investigator and Educator awards. The committee nominates members for fellowship status and elected offices within the PRN and the College. Jack Chen was elected this spring as the new Chair-Elect, and Collin Hovinga was elected as the Secretary/Treasurer.

Student Travel Award
The CNS PRN will award its first travel grant for $500 for one student who will be presenting a poster in the area of CNS (psychiatry or neurology) at the ACCP Annual Meeting. Eligible candidates must meet the following criteria: (1) student member of ACCP, (2) full-time pharmacy student pursuing his or her first professional pharmacy degree, and (3) presenter of a poster at the ACCP Annual Meeting. The selected student agrees to present his or her poster presentation at the CNS PRN business meeting.

Program Committee
Our focus session at the ACCP Annual Meeting in Pittsburgh will be “Management of the Patient with Traumatic Brain Injury” on Tuesday, October 18, 2011, from 3:30 p.m. to 5:30 p.m. Sunita Dergalust, Pharm.D., BCPS, will present “Emerging Treatment—Bench to Bedside” from 3:30 p.m. to 4:20 p.m. Stacia Wilhelm, Pharm.D., BCPS, will present “Treatment of the Behavioral Sequelae of TBI” from 4:20 p.m. to 5:10 p.m. This will be followed by a Q & A and panel discussion from 5:10 p.m. to 5:30 p.m.

Announcements
Kelly Lee and Collin Hovinga were recently elected as ACCP fellows and will be recognized at the upcoming ACCP Annual Meeting.
Vicki Ellingrod was elected Chair of the ACCP Research Institute Board of Trustees.
Barbara Wells is giving the Annual Fellows Address at the 2011 Fellows Dinner at the upcoming ACCP Annual Meeting.
Michele Splinter was a faculty mentor for an AACP-Walmart Scholar, Kshama Kumari, at the recent AACP annual meeting in San Antonio. She also presented Migraine, Parkinson Disease, and Seizure Disorders at the APhA annual meeting in Seattle in March and the ASHP annual meeting in Denver in June as part of the Ambulatory Care Pharmacy Review Course.
Lisa Hutchinson, Pharm.D., MPH, BCPS, was promoted to the rank of Professor at the University of Arkansas for Medical Sciences College of Pharmacy.

Keep Up-to-Date on the Latest in Critical Care at the ACCP Annual Meeting in Pittsburgh!

Hot Topics in Critical Care:

Monday afternoon, plan to attend programming developed by members of the Critical Care PRN in collaboration with the Society of Critical Care Medicine—“Sedation and Delirium in the ICU: Update on the Status of the 2011 SCCM Guidelines.” Faculty will discuss the major issues to be addressed by the updated SCCM guidelines on sedation; this discussion will assist critical care practitioners in establishing appropriate assessment and treatment strategies to optimize patient outcomes.

Tuesday morning, join your colleagues for programming developed by members of the Critical Care PRN—“Adverse Drug Events in the ICU: Learn Using High Fidelity Patient Simulation Cases.” This 2-hour session will discuss ADEs that are unrecognized in the ICU, identify drug-induced ADEs in complex cases, and describe the management of ADEs in simulated cases.

Tuesday afternoon, plan to attend programming developed by members of the Nephrology PRN —“AKI in the ICU: The Roles of Medication and CRRT.” In this 2-hour session, faculty will address important considerations in the use of continuous renal replacement therapy (CRRT) in critically ill patients with acute kidney injury (AKI).

Critical Care Research:

Check out critical care–related research displayed during the Scientific Poster Presentations, Platform Presentations, and Great Eight Best Paper Presentations.

Networking Opportunity:

Monday evening, the Critical Care PRN business meeting and networking forum will include a summary of PRN activities, reports from PRN officers, and presentation of the Resident/Fellow Research Travel Award. An informal reception will follow, allowing time for networking with new and old members, members collaborating on PRN-related projects, and trainees looking for job opportunities.

2011 Critical Care PRN Travel Awards

This year, the PRN awarded a Young Investigator Award and a Resident/Fellow Award. Each awardee will receive $1,250 and will present an overview of the projects during the PRN business meeting and networking forum at the 2011 Annual Meeting in Pittsburgh, Pennsylvania:

Kevin Kaucher, Pharm.D. (University of Rochester Medical Center, Rochester, New York), received the Young Investigator Award for his project titled “Relative Bioavailability of Oral Fosphenytoin Sodium Injection in Healthy Volunteers.”

Wesly Pierce, Pharm.D. (Medical University of South Carolina, Charleston, SC), received the Resident/Fellow Award for his project titled “Survey of HIT Laboratory Testing and Evaluation of Tailored HIT Screening Protocol Based on the ‘4-Ts’ Scoring System.”

Executive Summary from the Recognition Committee;

The Education and Training (EDTR) PRN membership has grown to more than 380 members who are advancing the PRN’s mission of promoting dialogue and interaction to develop programs that enhance the knowledge and skills needed to provide education and training within clinical pharmacy. The PRN and its members have accomplished much during the past several months.

At the ACCP Updates in Therapeutics® meeting in Columbus, Ohio, the PRN hosted a focus session on learner-centered teaching. This continuing education session was well attended and was available for elective credit to ACCP members who are participating in the Academy Certificate Program in Teaching and Learning or the Academy Certificate Program in Career Advancement. Several PRN members also attended the PRN networking breakfast held in Columbus.

Our Scholarly Activities Committee has finalized a position paper on implementing active learning in U.S. schools of pharmacy curricula. The paper was accepted by the American Journal of Pharmaceutical Education to be published in an upcoming issue. The committee is now planning the development of a book that will offer useful teaching tips for clinical faculty and preceptors. We are still seeking contributors for various chapters, especially from those who are interested in contributing teaching tips surrounding the topics of ethics and introductory and advanced practice experiences in inpatient teaching hospital settings. If you are interested in being a contributing author, please contact Tina Denetclaw.

The EDTR PRN Membership Committee has taken several steps toward increasing and retaining membership. The committee chair will now send an e-mail to new members welcoming them to the EDTR PRN. In addition, information about the PRN and about avenues for getting involved will be provided. New members are now also recognized at annual EDTR PRN networking meetings. Finally, the Membership Committee is developing promotional materials, which after peer review and revision, will be sent to each school of pharmacy’s ACCP liaison in hopes of increasing faculty membership.

The EDTR PRN is growing and would like to continue expanding its membership! We encourage ACCP members who are interested in promoting dialogue and interaction to enhance their knowledge and skills in improving clinical pharmacy education and training to join the EDTR PRN.

EDTR PRN Member Achievements include the following:

Heather P. Whitley, Pharm.D., BCPS, CDE

Publications:

Whitley HP. Monetary value of a prescription assistance program service in a rural family medicine clinic. J Rural Health 2011;27:190–5.

Grants:

Foster J, Whitley HP, Berns C, Thomas C. Capstone Rural Health Center Patient Safety and Clinical Pharmacy Collaborative. Coinvestigator; 2011: Project IMPACT: Diabetes Community. American Pharmacists Association Foundation. $25,000 on March 8, 2011. Status: funded

Whitley HP. Principal investigator; 2011: Diabetes Hands Foundation/Big Blue Test grant. $10,000 on August 17, 2011: funded

Dr. Whitley also became the 2011–2012 Chair of the Alabama Obesity Task Force.

Michael J. Peeters, Pharm.D., MEd, BCPS

Publications:

Peeters MJ. Cognitive development of learners in pharmacy education. Curr Pharm Teach Learn 2011;3:224–9.

Peeters MJ, Rivera CG. Biostatistics and parametrics. Pharmacotherapy 2011;31:63e–64e.

Presentations:

Evaluating student presentations. The Collaborative Education Institute, Online CE Presentation for Preceptors. July 2011.

Sarah McBane, Pharm.D., CDE, BCPS

Publications:

McBane S, Trewet CB, Nadra Havican S, Kiser K, Klingel C, Riche DM, Sease JM, Nau DP, Zillich AJ. Tenets for developing quality measures for ambulatory clinical pharmacy services. Pharmacotherapy 2011;31:115e–134e.

McBane S. Evolving pharmacy practice in the 21st century. Drug Topics Jan 2011:44–55.

McBane S. Drugs in dermatology: ivermectin in the treatment of scabies. JDPA 2011;5:33.

McIntosh J, Rafie S, Wasik M, McBane S, Lodise N, El-Ibiary S, Forinash A, Kachlic M, Rowe E, Besinque K. Changing oral contraceptives from prescription to over-the-counter status: an opinion statement of the Women’s Health Practice and Research Network of the American College of Clinical Pharmacy. Pharmacotherapy 2011;31:424–37.

McBane S, Rojas C. Azathioprine-induced fever in sarcoidosis. Ann Pharmacother 2011;45:e19.

McBane S, Halstater B. Evaluation of beliefs about hypertension in a general population J Prim Care Community Health 2011;2:96–9.

Amy Tiemeier, Pharm.D., BCPS

Publications:

Tiemeier AM, Stacy ZA, Burke JM. Using multiple-choice questions written at various Bloom’s taxonomy levels to evaluate student performance across a therapeutics sequence. Innov Pharm 2011;2:Article 41.

Beth H. Resman-Targoff, Pharm.D., FCCP

Publications:

Resman-Targoff BH, Cicero MP. Aggressive treatment of early rheumatoid arthritis: recognizing the window of opportunity and treating to target goals. Am J Manag Care 2010;16:S249–S258.

Dr. Resman-Targoff was also named 2011 Oklahoma Society of Health-System Pharmacists Pharmacist of the Year.

Dr. Resman-Targoff provided three podcast interviews in the series titled “From Principle to Practice: Interprofessional Perspectives on Early RA. What Do the Updated RA Classification Criteria Mean for You?” This is a CME/CE-accredited activity through the Center for Independent Healthcare Education (www.jointsponsor.com), 2011.

Andrea S. Franks, Pharm.D., BCPS
Dr. Franks was accepted into the American Association of Colleges of Pharmacy’s Academic Leadership Fellows Program for 2011–2012.

Brenda L. Gleason, Pharm.D.
Dr. Gleason was accepted into the American Association of Colleges of Pharmacy’s Academic Leadership Fellows Program for 2011–2012.

Rebecca B. Sleeper-Irons, Pharm.D., FASCP, BCPS
Dr. Sleeper-Irons became the new Associate Dean of Curricular Affairs at Texas Tech.

Amie Blaszczyk, Pharm.D., BCPS, CGP
Dr. Blaszczyk recently became the new Head of the Geriatrics Division at Texas Tech.

Marianne Koenig, Pharm.D., B.S., BCPS
Dr. Koenig was recently appointed Assistant Professor and Coordinator of Clinical Academic Simulation at University of South Florida College of Pharmacy.

Current Officers
Chair: Pamela Lada Walker, Pharm.D., BCPS
Chair-Elect: Kevin O. Rynn, Pharm.D., DABAT, FCCP
Secretary/Treasurer: Mary Beth Shirk, Pharm.D.
Media Chair: Wichitah P. Leng, Pharm.D.

ACCP Annual Meeting: Tuesday, October 18, 2011, Pittsburgh, Pennsylvania
Please join the Emergency Medicine PRN for its business meeting and networking forum; members and interested meeting attendees are welcome. The business meeting will include an update of PRN activities and initiatives as well as an opportunity to become involved in the PRN and meet others with interests and practices in emergency medicine. From 6:30 p.m. to 7:30 p.m., there will be a presentation titled “Lipids, Not Just for Breakfast Anymore” by Renee Petzel, Pharm.D., which will be available for 1 hour of continuing pharmacy education credit. Light hors d’oeuvres and beverages will be provided.

The Emergency Medicine PRN would like to acknowledge and congratulate all of its members on their accomplishments and achievements:

Presentations:

Acquisto NM, Bankey PE, Haas CE. Implementation and evaluation of a recombinant activated factor VII guideline for uncontrolled bleeding. American College of Clinical Pharmacy Annual Meeting. Pittsburgh, PA, October 2011.

Kaucher K, Haas CE, Acquisto NM, et al.
Relative bioavailability of oral fosphenytoin sodium injection in healthy volunteers. American College of Clinical Pharmacy Annual Meeting. Pittsburgh, PA, October 2011.

Iannolo M, Mah ND, Acquisto NM, Gross JM, Ketz JP, Prasarn ML, Humphrey CA, Gorczyca JT. Can we prevent renal failure by using ciprofloxacin instead of gentamicin for the treatment of open fractures in older patients? Orthopaedic Trauma Association 27th Annual Meeting. San Antonio, TX, October 2011.

Patanwala AE, Sanders AB, Thomas MC, Acquisto NM, et al. A prospective, multicenter study of medication errors intercepted by emergency department pharmacists. American College of Emergency Physicians Scientific Assembly. San Francisco, CA, October 2011.

Publications:

Kyle A. Weant, Pharm.D., BCPS

Weant KA, Winstead PS, Armitstead JA. Alternative pharmacy practice model. Am J Health Syst Pharm 2011;68:1395–6.

Cook A, Lemon S, Ashton J, Weant KA, Gross K, Winstead PS. Survey of critical care education in US colleges of pharmacy. Curr Pharm Teach Learn 2011. In press.

Walsh K, Davis GA, Hayes D, Kuhn R, Weant KA, Flynn JF. Tobramycin pharmacokinetics in patients with cystic fibrosis before and after bilateral lung transplantation. Transpl Infect Dis 2011. In press.

Weant KA, Weant MP. The safety and efficacy of glucagon for relief of esophageal food impaction. Am J Health Syst Pharm 2011. In press.

MacLaren R, Dager W, Bolesta S, Brophy G, Dell K, Gerlach A, Kristeller J, Micek S, Hess M, Bentley M, Juang P, Kane-Gill S, Haase K, Mann H, Miller C, Pepe D, Southwood R, Weant K, Rebuck J, Wood C. An opinion paper outlining recommendations for training, credentialing, and documenting and justifying critical care pharmacy services. Pharmacotherapy 2011. In press.

Baker SN, Weant KA. Therapeutic hypothermia. Adv Emerg Nurs J 2011. In press.

Baker SN, Weant KA. Procedural sedation and analgesia in the emergency department. J Pharm Pract 2011;24:189–95.
Ashton J, Baker SN, Weant KA. When snakes bite: the management of North American Crotalinae snake envenomation. Adv Emerg Nurs J 2011;33:15–22.

Weant KA, Humphries R, Hite K, Armitstead J. Effect of emergency medicine pharmacists on medication error reporting in the emergency department. Am J Health Syst Pharm 2010;67:1851–5.

Pandya KA, Ruf KM, Winstead PS, Cook AM, Weant KA. Pharmacy resident participation with a 24-hour multidisciplinary stroke response team. Am J Health Syst Pharm 2010;67:1901, 1905–7.

Weant KA, Armitstead JA. Emergency medicine pharmacy. Am J Health Syst Pharm 2010;67:1595–7.

Derek M. Polly, Pharm.D.

Polly DM, Paciull CA, Hatfield CJ. Management of hypertensive emergency and urgency. Adv Emerg Nurs J 2011;33:127–36.

Darrel W. Hughes, Pharm.D., BCPS
Faust AC, Terpolilli R, Hughes DW. Management of toxicities after oral ingestion of transdermal fentanyl patches: a case report and literature review. Case Report Med 2011;2011:495938.

Munoz MA, Maxwell PR, Green K, Hughes DW, Talbert RL. Pravastatin versus simvastatin for prevention of contrast-induced nephropathy. J Cardiovasc Pharmacol Ther. Accepted March 8, 2011.

Adam Solola, Pharm.D., MBA

Solola AO. Assessing the need for a pharmacist in the emergency department of an IHS hospital. Fed Pract 2011;28:29–32, 36.

Asad (Sid) Patanwala, Pharm.D., BCPS

Snyder EM, Wong EC, Foxx-Lupo WT, Wheatley CM, Cassuto NA, Patanwala AE. Effects of an inhaled ß(2)-agonist on cardiovascular function and sympathetic activity in healthy subjects. Pharmacotherapy 2011;31:748–56.

Patanwala AE, Acquisto NM, Erstad BL. Prothrombin complex concentrate for critical bleeding. Ann Pharmacother 2011;45:990–9.

Traylor BR, Wheatley CM, Skrentny TT Jr., Foxx-Lupo WT, Phan H, Patanwala AE, Morgan WJ, Daines CL, Sprissler R, Snyder EM. Influence of genetic variation of the β(2)-adrenergic receptor on lung diffusion in patients with cystic fibrosis. Pulm Pharmacol Ther 2011;24:610–6.

Patanwala AE, Hays DP, Sanders AB, Erstad BL. Severity and probability of harm of medication errors intercepted by an emergency department pharmacist. Int J Pharm Pract 2011;19:358–62.

Patanwala AE, Biggs AD, Erstad BL. Patient weight as a predictor of pain response to morphine in the emergency department. J Pharm Pract 2011;24:109–13.

Patanwala AE. Acute pain management. In: Katz MD, Matthias KR, Chisholm-Burns MA, eds. Pharmacotherapy Principles and Practice Study Guide. New York: McGraw-Hill, 2011.

Nicole Acquisto, Pharm.D., BCPS

Acquisto NM, Hays DP, Fairbanks RJ, et al. The outcomes of emergency pharmacist participation during acute myocardial infarction. J Emerg Med. 2010 Aug 31. [Epub ahead of print]

Acquisto NM, Baker SN. Antimicrobial stewardship in the emergency department. J Pharm Pract 2011;24:196–202.

Acquisto NM, Gelbard WB. Medication use during pregnancy. Emerg Med Rep 2011;32:1–15.

Patanwala AE, Acquisto NM, Erstad BL. Prothrombin complex concentrate for critical bleeding. Ann Pharmacother 2011;45:990–9.

Wiegand T, Acquisto NM. High-dose flumazenil drip for reversal of a massive iatrogenic benzodiazepine overdose. A cause-effect analysis of an adverse drug effect and discussion of the role of the clinical pharmacist and medical toxicologist. The American Academy of Clinical Toxicology Annual Meeting. Washington, DC, September 2011.

Other Notable Achievements:

EMED PRN Research Project
Members of the EMED PRN led by Sid Patanwala completed a multicenter research project to determine both the methods by which patients with medication errors (MEs) were first identified in the emergency department (ED) by the ED pharmacist and the activities that led up to the ME interception. A total of 16,446 patients were encountered during the study, resulting in 364 confirmed ME interceptions by pharmacists in the ED. After analysis, members determined that medical and nursing staff–initiated contact with the ED pharmacist is necessary to identify a large proportion of patients at risk of MEs and that pharmacist review of written or computerized medication orders accounts for fewer ME interceptions than expected.

New Partnering Program
We are excited to announce that the EMED PRN has created a new program—the Collaborative Organization for Development of Emergency Medicine Pharmacists (CODE Program). The purpose of the program is to encourage idea sharing and foster professional growth by forming meaningful partnerships among EM pharmacists. Each year, the program will match participants on the basis of personally identified strengths and goals according to a “Participant Bio” form. This document is located on the EMED PRN homepage under “PRN Documents/CODE Program Documents” or by using the link provided below.

Are you willing to serve as a resource for protocol development? Would you like to collaborate with someone who is experienced in survey research? Have you been active in organizations and would now like to help a colleague become more involved? The Participant Bio encourages you to indicate specific areas, including clinical practice, research, teaching, organization involvement, or career development, in which you would like to serve as a resource as well as areas in which you hope to gain more experience. Our hope is that communication among partners will take place throughout the year in a way that best suits the needs of both areas (i.e., quarterly e-mails, ACCP conferences, or any time a question arises).

We realize that emergency medicine pharmacy practice is an emerging area and that strong collaboration is essential to the EMED PRN’s success. EM pharmacists are making a difference across the nation. By joining forces with like-minded professionals, we can achieve even more. We all share a common goal—developing best practices for patients in the acute care setting. Join us in taking this next step to work together, advancing our practice!

The registration process for this year has been completed, and match results were sent to participants on September 1, 2011 (see results below). Be sure to look for updates regarding the upcoming year’s registration process, and feel free to speak to any of the committee members if you have questions.

Important links:
Participant Bio
CODE Program Flyer

The Endocrine and Metabolism PRN is composed of members from a variety of practice settings. This PRN was formed to achieve the following goals and objectives. (1) Provide an opportunity for pharmacists with an interest in endocrine and metabolism disorders to promote practice, research, and education in these areas. (2) Provide a mechanism for members with similar interests to meet during ACCP meetings to network, perform problem solving, and discuss professional issues and opportunities. (3) Promote practice involvement; the educational needs of health care professionals, students, and patients; and research activities in the areas of endocrinology and metabolism that may be favorably affected by this ACCP PRN effort.

During the past 6 months, some notable member accomplishments are as follows.

Publications:

Amy Donihi, Pharm.D., BCPS
DiNardo M, Donihi AC, Forte P, Gieraltowski L, Korytkowski MT. Standardized glycemic management improves peri-operative glycemic outcomes in same-day surgery patients with diabetes. Endocr Pract 2011;17:404–11.

Donihi AC, Gibson J, DiNardo M, Koerbel G, Korytkowski MT. Role of a targeted glycemic management team in an academic medical center. Endocr Pract 2011;17:552–7.

Leigh Ann Ross, Pharm.D., BCPS
Ross LA. Pharmacists as mid-level practitioners/providers. Ann Pharmacother 2011;45:810–2.

June Johnson, Pharm.D., B.S., FASHP, BC-ADM
Ryan G, Chesnut R, Odegard PS, Dye JT, Jia H, Johnson JF. The impact of diabetes concentration programs on pharmacy graduates’ provision of diabetes care services. Am J Pharm Educ 2011;75:1–7.

Krystal Edwards, Pharm.D., BCPS and Lisa Chastain, Pharm.D.
Edwards K, Chastain LM, Snodgrass L, Martin A, Busti AJ. Effects of combined use of antiretroviral agents and atypical antipsychotics on lipid parameters. J Antivir Antiretrovir 2011;3:034–039.

Abstracts/Posters:

Communications Committee
Endocrine and Metabolism PRN Updates and Report on the Benefit with an Online Journal Club
Amy C. Donihi, Pharm.D., BCPS; Rohit Moghe, Pharm.D., MSPH; Emily Vescovi, Pharm.D., BCPS; Jennifer N. Clements, Pharm.D., BCPS, CDE; Rick Hess, Pharm.D., BC-ADM, CDE; Craig Logemann, Pharm.D., BCPS, CDE; L. Kent Porter, Pharm.D., M.S.

Awards and Honors:

Brian Irons, Pharm.D., BCPS, BC-ADM; June Johnson, Pharm.D., B.S., FASHP, BC-ADM; and Leigh Ann Ross, Pharm.D., BCPS, have been elected fellows of the American College of Clinical Pharmacy and will be recognized during a special ceremony on October 16 at the College’s 2011 Annual Meeting in Pittsburgh, Pennsylvania.

Marissa Escobar Quinones, Pharm.D., received the 2011 Diabetes Educator of the Year Award representing Southeast Dallas Health Center Pharmacy. The Southeast Dallas Center also received the 2011 Site of the Year Award for outstanding outcomes in the Health Living Diabetes Program.

Daniel Riche, Pharm.D., BCPS, CDE, will receive the 2011 New Clinical Practitioner Award, honoring him as a new clinical practitioner who has made outstanding contributions to the health of patients and/or the practice of clinical pharmacy.

Evan Sisson, Pharm.D., BCPS, CDE, has been nominated as a candidate on the 2012 slate for Research Institute Trustee.

Krystal Edwards, Pharm.D., BCPS, received the award for 2010–2011 Faculty Preceptor of the Year at Texas Tech University Health Sciences Center School of Pharmacy – Dallas/Fort Worth campus.

Other Accomplishments:

Jennifer Goldman-Levine, Pharm.D., FCCP, BC-ADM, CDE, was promoted to Professor at Massachusetts College of Pharmacy and Health Sciences.

Dawn Havrda, Pharm.D., FCCP, BCPS, was promoted to Professor at Shenandoah University, Bernard J. Dunn School of Pharmacy.

Brian Irons, Pharm.D., BCPS, BC-ADM, provided the Endocrine and Metabolism PRN presentation at the Pharmacotherapy Preparatory Course Review in April 2011 at Columbus, Ohio. In addition, Dr. Irons was elected 2011–2012 Secretary for the Ambulatory Care PRN.

Michael Kane, Pharm.D., FCCP, BCPS, provided the Endocrine and Metabolism PRN presentations at the Ambulatory Care Preparatory Course Review in April 2011 at Columbus, Ohio.

Angela Hodges, Pharm.D., was promoted to Clinical Pharmacist Diabetes Specialist at Huguley Memorial Medical Center in Fort Worth, Texas.

Edward Allie, Pharm.D., BCPS, accepted a new position as Clinic Pharmacy Performance Manager for Steward Health Care Network.

Michelle Rager, Pharm.D., BCPS, and Jessica Trompeter, Pharm.D., MBA, BCPS, passed the examination for Certified Diabetes Educator in early summer 2011.

PRN Officer and Committee Updates:
The Endocrine and Metabolism PRN would like to congratulate the newly elected officers:
Chair-Elect: Jennifer N. Clements, Pharm.D., BCPS, CDE
Secretary/Treasurer: Nicole Pinelli, Pharm.D., M.S., CDE

2011 Focus Session:

The Education Committee is working on the programming for the fall 2011 focus session for the Annual Meeting in Pittsburgh, Pennsylvania, titled “Rapid Clinical Pearls and a Clinical Debate in Endocrinology and Metabolism.” The goal of the session is to review several controversial topics in the fields of endocrinology and metabolism. The program will be held Monday, October 17, from 3:45 p.m. to 5:45 p.m. The topics and speakers will be as follows:

Emerging Therapies in Diabetes
Nicole Pinelli, Assistant Professor of Pharmacy Practice, Wayne University, Eugene Applebaum College of Pharmacy and Health Sciences, Detroit, Michigan

GLP-1 Agents in Metabolic Syndrome/Obesity
Rick Hess, Assistant Professor, Department of Pharmacy Practice, Bill Gatton College of Pharmacy at East Tennessee State University

Metformin Use for Chronic Kidney Disease Patients
Marissa Quinones, Clinical Pharmacy Specialist, Parkland Southeast Dallas Health Center, Grand Prairie, Texas

Glucose Variability Impact
Kim Kelly, President, Kelly Diabetes Associates, LLC, Cupertino, California

U-500: Appropriate Use and Common Pitfalls
Jessica Trompeter, Assistant Professor, Bernard J. Dunn School of Pharmacy, Winchester, Virginia

ADA Algorithm vs. AACE Algorithm for Diabetes
Craig Logemann, Clinical Pharmacist, Partners in Health Clinics, Des Moines, Iowa

Tricia M. Russell, Assistant Professor, Department of Pharmacy Practice, Wilkes University, Nesbitt School of Pharmacy and Nursing, Wilkes-Barre, Pennsylvania

2011 Business Meeting:

The PRN officers hope many current and interested members will join the Endocrine and Metabolism PRN business meeting at the Annual Meeting in Pittsburgh, Pennsylvania. The Endocrine and Metabolism PRN will hold a business meeting and networking forum to solicit membership and enhance resident/student participation. The scheduled activities will include a roundtable discussion and the PRN’s annual business meeting, with a planned networking event to follow. The meeting will be held on Tuesday, October 18, at 6:00 p.m. at the Westin Convention Center Pittsburgh Hotel, Butler Room.

Weekly Online Journal Club:

The Communications Committee continues to lead the PRN in the weekly online journal club on its PRN e-mail list. The online journal club was implemented in February 2010; so far, the committee has reviewed more than 100 articles in the past 12 months. The purpose of the online journal club is to provide an awareness of key articles that add new information to the fields of endocrine and metabolism. Members of the PRN are asked to contribute articles and comments periodically. Active members from the Communications Committee have been soliciting journal club articles from the PRN e-mail list and have been posting two articles each week. The following members have been involved in continuing the weekly online journal club: Jennifer Clements (Communications Committee chair), Emily Vescovi (member), Craig Logemann (member), Richard Hess (member), Rohit Moghe (member), Kent Porter (member), and Amy Calabrese Donihi (member). Please contact Jennifer Clements, [email protected], for more information about the online journal club.

Congratulations to the following members who completed their postgraduate training in 2011!

Ginny Crisp, Pharm.D., completed a PGY2 geriatric specialty residency at UNC Hospitals and Clinics/UNC Eshelman School of Pharmacy in NC.

Marian James, Pharm.D., completed a PGY2 geriatric specialty residency at Kingsbrook Jewish Medical Center in NY.

Lindsay Saum, Pharm.D., CGP, completed a PGY2 geriatric specialty residency at the Charleston Area Medical Center/West Virginia University CAMC in WV.

Scott Vouri, Pharm.D., completed a PGY2 geriatric specialty residency at Texas Tech University HSC School of Pharmacy in Texas.

Zachary A. Marcum, Pharm.D., M.S., BCPS, completed a geriatric fellowship at the University of Pittsburgh in PA.

New Positions and Promotions:

Lisa C. Hutchison, Pharm.D., MPH, BCPS: Full Professor at the University of Arkansas for Medical Sciences in AR.

Marian James, Pharm.D.: Geriatric Clinical Pharmacist at Kingsbrook Jewish Medical Center in NY.

Lindsay Saum, Pharm.D., CGP: Clinical Pharmacist of Internal Medicine at St. Vincent Health and Assistant Professor of Pharmacy Practice at Butler University in IN.

Zachary A. Marcum, Pharm.D., M.S., BCPS: Assistant Professor at the University of Pittsburgh in PA.

Peggy Odegard, Pharm.D.: Full Professor and Chair of the Department of Pharmacy at the University of Washington in WA.

Amie Taggart Blaszczyk, Pharm.D., FASCP, BCPS, CGP: Division Head of Geriatrics at the Texas Tech University HSC School of Pharmacy in TX.

Scott Vouri, Pharm.D.: Assistant Professor of Geriatrics at the St. Louis College of Pharmacy in MO.

Publications

Hanlon JT, Wang X, Castle NG, Stone RA, Handler SM, Semla TP, Pugh MJ, Berlowitz DR, Dysken MW. Potential underuse, overuse and inappropriate use of antidepressants in older veteran nursing home patients. J Am Geriatr Soc 2011;59:1412–20.

Reid MC, Bennett DA, Chen WG, Eldadah BA, Farrar JT, Ferrell B, Gallagher RM, Hanlon JT, Herr K, Horn SD, Inturrisi CE, Lemtouni S, Lin YW, Michaud K, Morrison RS, Neogi T, Porter LL, Solomon DH, Von Korff M, Weiss K, Witter J, Zacharoff K. Improving the pharmacologic management of pain in older adults: identifying the research gaps and methods to address them. Pain Med 2011;12:1336–57.

Hilas O, Ezzo DC. Immunizations in the elderly. ACCP PSAP-VII: Geriatrics 2011;197–212.

Hilas O, Avena-Woods C. Neurocardiogenic syncope: a focus on the management of vasovagal episodes. US Pharm 2011;36:HS2–HS11.

Hughes GJ, Belgeri MT, Perry HM. The impact of pharmacist interventions on the inappropriate use of acid-suppression therapy. Consult Pharm 2011;26:485–90.

Hughes GJ, Patel PN, Saxena N. Effect of acetaminophen on international normalized ratio in patients receiving warfarin therapy. Pharmacotherapy 2011;31:591–7.

Hume AL, Quilliam BJ, Eaton CB, Goldman R, Lapane KL. Alternatives to potentially inappropriate medications for use in e-prescribing software: triggers and treatment algorithms. BMJ Qual Saf 2011 June 30. [Epub ahead of print]

Jackson-Derezza A, Hume AL. Aspirin for CV prevention—for which patients? J Fam Pract 2011;60:518.

Lee JK, De Los Santos K. Dyslipidemia. In: Katz M, Matthias K, Chisholm-Burns MA, eds. Pharmacotherapy Principles and Practice Study Guide: A Case-Based Care Plan Approach. New York: McGraw-Hill, 2010:51–3.

Lee JK, Davis S. Gastroesophageal reflux disease. In: Katz M, Matthias K, Chisholm-Burns MA, eds. Pharmacotherapy Principles and Practice Study Guide: A Case-Based Care Plan Approach. New York: McGraw-Hill, 2010:67–9.

Byers MG, Allison KM, Wendel CS, Lee JK. Prazosin versus quetiapine for nighttime posttraumatic stress disorder symptoms in veterans: an assessment of long-term comparative effectiveness and safety. J Clin Psychopharmacol 2010;30:225–9.

Chisholm-Burns MA, Lee JK, Spivey C, et al. U.S. pharmacists’ effects as team members on patient care: systematic review and meta-analyses. Med Care 2010;48:923–33.

Chisholm-Burns MA, Graff Zivin JS, Lee JK, et al. Economic effects of pharmacists on health outcomes in the United States: a systematic review. Am J Health Syst Pharm 2010;67:1624–34.

Romero JJ, Lee JK. Is one ceruminolytic more effective than another? Ariz Geriatr Soc J 2010;15:22–3.

Lee JK. Depression in older adults—pharmacotherapy. In: Elder Care: A Resource for Interprofessional Providers. Available at www.reynolds.med.arizona.edu/EduProducts/ElderCareProviderSheets.cfm. Accessed September 26, 2011.

O’Connell MB, Borgelt LM, Bowles SK, Vondracek SF. Drug-induced osteoporosis in the older adult. Aging Health 2010;6:501–18.

Colon-Emeric C, O’Connell MB, Haney E. The osteoporosis piece of the multi-morbidity puzzle. Mt Sinai Med J 11;78:515–26.

Peron EP, Marcum ZA, Boyce R, Hanlon JT, Handler SM. Year in review: medication mishaps in the elderly. Am J Geriatr Pharmacother 2011;1:1–10.

Sleeper RB, Blaszczyk AT. Dizziness and syncope in the elderly. ACCP PSAP-VII: Geriatrics 2011;97–114.

The GI/Liver/Nutrition PRN continues to grow. The latest membership report from ACCP for September 2011 indicates that there are now 169 members. The results of the PRN officer elections were released this month. Rima Mohammad has been elected Chair-Elect, and Pramodini Kale-Pradhan has been elected Secretary/Treasurer for the 2011–2012 term. Joseph Ybarra will be the Chair for 2011–2012. Special thanks to Joseph Ybarra and Sheila Wilhelm in their roles as Chair-Elect and Secretary/Treasurer for the past year. The PRN business meeting will be held in Pittsburgh on the evening of Tuesday, October 18. We hope you will join us to network and socialize with your colleagues from around the country. The PRN educational focus session will also be on Tuesday and will cover the topics listed below. We hope you will be able to attend.

Annual Meeting GI/Liver/Nutrition Focus Session

Contemporary Issues in the Management of Total Parenteral Nutrition

Tuesday, October 18, 3:30 p.m. - 5:30 p.m.

Session Goals
1. Provide updates in the management of total parenteral nutrition (TPN) in patients with acute and chronic kidney disease.
2. Discuss the impact of hemodialysis or continuous renal replacement therapies on the management of TPN.
3. Review approaches to dosing and monitoring of TPN in obese patients.
4. Recommend strategies for micronutrient supplementation and management of long-term adverse effects of TPN.

TITLE: Management of TPN in Patients with Kidney Disease
PRESENTER: Sarah Nordbeck
PRESENTATION LENGTH: 35 minutes
LEARNING OBJECTIVES:
1. Review current recommendations for dosing and monitoring of TPN in patients with acute, chronic, and end-stage kidney disease.
2. Discuss the management of TPN in patients undergoing hemodialysis or continuous renal replacement therapies.
3. Discuss potential complications of TPN therapy in patients with chronic or end-stage kidney disease.

TITLE: Management of TPN in Patients with Obesity
PRESENTER: Erin Nystrom
PRESENTATION LENGTH: 35 minutes
LEARNING OBJECTIVES:
1. Review the appropriate roles for both acute and chronic TPN therapy in obese patients.
2. Provide recommendations for dosing and monitoring of TPN in patients with obesity.
3. Discuss potential complications of TPN therapy in patients with obesity.

TITLE: Micronutrient Supplementation and Long-term Adverse Effects of TPN Therapy
PRESENTER: Leslie Hamilton
PRESENTATION LENGTH: 35 minutes
LEARNING OBJECTIVES:
1. Review the role and appropriateness of micronutrient supplementation in patients receiving TPN therapy.
2. Provide recommendations for dosing and monitoring of micronutrient supplementation in acute and chronic TPN therapy.
3. Discuss strategies for prevention and management of long-term adverse effects of TPN therapy.

Member Accomplishments:

Christine Walko, Pharm.D., was named UNC Eshelman School of Pharmacy Professor of the Year for 2010–2011. Dr. Walko also published original research in JCO:
Irvin WJ, Walko CM, Weck KE, et al. Genotype-guided tamoxifen dosing increases active metabolite exposure in women with reduced CYP2D6 metabolism: a multicenter study. J Clin Oncol 2011;29:3232–9.

The Hematology/Oncology PRN has chosen its first annual PGY2 Oncology Pharmacy Resident of the Year Award recipient: Kelly Valla, Pharm.D., Hematology/Oncology Clinical Pharmacy Specialist
Emory Healthcare/Emory University Hospital/Winship Cancer Institute

The Hematology/Oncology PRN has awarded its 2011 Student/Resident Travel Award to Kevin Curler, Pharm.D., MBA. Dr. Curler is a Pharmacy Practice Resident at UCSF Medical Center.

New officers elected by the Hematology/Oncology PRN for the 2011–2012 term are as follows:
Becky Fahrenbruch Pharm.D., BCOP – Chair-Elect
Sal Bottiglieri, Pharm.D. – Secretary/Treasurer

Newly Inducted Fellows:

The PRN would like to congratulate the following members on their induction as fellows of ACCP. Their contributions to the practice of pharmacy and ACCP are greatly appreciated.

Steve Gabardi, Pharm.D., FCCP, BCPS
Lisa McDevitt-Potter, Pharm.D., FCCP, BCPS
Christin Rogers, Pharm.D., FCCP, BCPS

Newly Elected Leaders for 2011–2012:

We want to congratulate and introduce the newly elected PRN leadership.

Steve Gabardi will be the Chair of the PRN for the coming year. Angela Maldonado is the new Chair-Elect for the coming year. Jennifer Trofe-Clark will be the new Secretary/Treasurer. Please congratulate these new officers when you see them at the upcoming ACCP Annual Meeting.

Immunology/Transplantation-Related Abstracts at the Annual Meeting:

The following are transplant-related poster presentations that PRN members may be interested in attending.

Monday, October 17

258. Evaluation of a Preemptive Strategy for CMV Disease Prevention in Cardiac Transplant Patients. Edward T. Horn, Pharm.D., BCPS, et al.

259. Corticosteroid Withdrawal in Renal Transplant Recipients: An Analysis of the Mycophenolic Acid Observational Renal Transplant Registry. Kimi Ueda Stevenson, Pharm.D., BCPS, et al.

260. Early Analyses of Renal Transplant Recipients Who Received Expanded Criteria Donor Kidneys from the Mycophenolic Acid Observational Renal Transplant Registry. Kimi Ueda Stevenson, Pharm.D., BCPS, et al.

261. Comparisons of Enteric-Coated Mycophenolate Sodium and Mycophenolate Mofetil Outcomes from the Mycophenolic Acid Observational Renal Transplant Registry. Ali Olyaei, Pharm.D., BCPS, et al.

262. African American Renal Transplant 1-Year Outcomes from the Mycophenolic Acid Observational Renal Transplant Registry. Lonnie Smith, Pharm.D., et al.

263E. Steroid-Free, Calcineurin Inhibitor Minimizing Regimen with Long-term Mycophenolate Mofetil Monotherapy for HLA Identical Living Donor Kidney Transplantation: Long-term Outcomes. Adele R. Shields, Pharm.D., et al.

264. A Prospective, Single-Center, Pilot Study of Pre-transplant Thymoglobulin Administration and Early Corticosteroid Withdrawal in Living Donor Renal Transplant Recipients. Adele R. Shields, Pharm.D., et al.

265. Pepper Mould Contamination Risk to Immunocompromised. John D. Cleary, Pharm.D., et al.

266. Use of HMG-CoA Reductase Inhibitors in Liver Transplant Patients with Recurrent Hepatitis C Virus. Sarah E. Yost, Pharm.D., et al.

268E. Comparison of Calcineurin Inhibitor Administration Post-heart Transplantation. Cory Blacksmith, Pharm.D., et al.

270. Impact of Immunosuppressant Regimen on the Onset of Hyperlipidemia in Kidney Transplant Recipients. Shelby L. Corman, Pharm.D., et al.

271. A Single-Center Experience with Conversion Between Two Generic Tacrolimus Formulations. Eric Tichy, Pharm.D., BCPS, et al.

470F. Effectiveness and Safety of Influenza Vaccine in the First 6 Months Post-lung Transplant. Kalynn A. Rohde, et al.

Tuesday, October 18

269F. Cardiovascular Events and CV-Related Mortality After Renal Transplantation: Effect of Maintenance Steroid Therapy and Preexisting Coronary Artery Disease. Adele R. Shields, Pharm.D., et al.

383. Tacrolimus Trough Concentrations in Heart Transplant Recipients During Episodes of Acute Cellular Rejection. Gretchen Kipp, Pharm.D., et al.

384. Early Corticosteroid Withdrawal Reduces Risk for Actual Cardiovascular Events in Renal Transplant Recipients: A Multivariate Analysis. Nicole M. Schmidt, Pharm.D., et al.

385. 10-Year Experience with Early Corticosteroid Elimination in Kidney Transplantation: Analysis of Patient and Graft Survival. Nicole M. Schmidt, Pharm.D., et al.

386. Multivariate Analysis of Risk Factors That Influence Graft Survival Following Proteasome Inhibitor Therapy for Antibody-Mediated Rejection. Basma Sadaka, Pharm.D., et al.

387. Preservation of Renal Function with Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Therapy Early After Heart Transplantation. David Johnson, Pharm.D., et al.

Wednesday, October 19

487E. Impact of Conversion to Sirolimus-Based Immunosuppression on Fibrosis Progression in HCV+Liver Transplant Recipients. Christin Rogers, Pharm.D., et al.

PRN Member Platform Presentation

Monday, October 17

The Great Eight
259. Corticosteroid Withdrawal in Renal Transplant Recipients: An Analysis of the Mycophenolic Acid Observational Renal Transplant Registry. Kimi Ueda Stevenson, Pharm.D., BCPS, et al.

Tuesday, October 18
272. Is Valganciclovir a Viable Option for Cytomegalovirus (CMV) Prophylaxis in Liver Transplantation? Gregory Smallwood, Pharm.D., B.S.

Immunology/Transplantation PRN Programming at the ACCP Annual Meeting:

Please join the PRN at these transplant-focused sessions at the Annual Meeting:

Long-term Management of the Renal Transplant Recipient, Monday, October 17, 1:30 p.m.–3:30 p.m.
Symposium on the Management of Complications after Organ Transplantation, Tuesday, October 18, 1:30 p.m.–4:30 p.m.

Immunology/Transplantation PRN Business Meeting and Networking Forum:

The PRN business meeting will be held Monday, October 17, from 6:00 p.m. to 9:00 p.m. At the meeting, we will have our annual resident debate. This year’s topic is a pro versus con debate on hepatitis C virus protease inhibitor therapy post-liver transplant. Gretchen Kipp, Pharm.D., will present the pro argument. Daniel Migliozzi, Pharm.D., will present the con argument. There will also be a presentation titled “The Clinical and Financial Impact of the Transplant Pharmacist” by Dave Taber, Pharm.D., BCPS. Supported in part by a grant from Astellas Pharma Global Development

Update on Board Certification in Pain and Palliative Care:

The following PRN members have been appointed by the Board of Pharmacy Specialties (BPS) to serve on the Pain and Palliative Care Practice Analysis Task Force:

-Jeffrey Fudin, Pharm.D., DAAPM, FCCP
-Phyllis Grauer, Pharm.D., CGP
-Christopher Herndon, Pharm.D., BCPS, CPE
-Lee Kral, Pharm.D., BCPS
-Mary Lynn McPherson, Pharm.D., BCPS, CPE
-Suzanne Nesbit, Pharm.D., CPE

This task force will work closely with BPS as part of a role delineation study to determine whether pain and palliative care pharmacy is based on specialized knowledge and functions. Through their work with BPS, these PRN members seek to guide the development of a pain and palliative care certification program. In addition, many members of our PRN will serve as expert reviewers as the role delineation study progresses throughout the year. Thank you to all of our PRN members for their participation in this important process!

PRN Focus Session at the 2011 Annual Meeting:

In collaboration with the Pharmaceutical Industry and Hematology/Oncology PRNs, we will host a session on the role of clinical pharmacists in Risk Evaluation and Mitigation Strategies (REMS) programs on Monday, October 17, from 1:30 p.m. to 3:30 p.m. This session is intended to educate the audience regarding the role of REMS programs as they influence pharmacovigilance/safety monitoring from an industry perspective, clinical pharmacy practice, and patient care. The speakers for this session include the following individuals:

Cynthia LaCivita, Pharm.D. – Drug Risk Management Analyst (RMA), Division of Risk Management, FDA/CDER/Office of Surveillance and Epidemiology, Silver Spring, Maryland
Joseph F. Heissler Jr., Pharm.D., BCPS – Director, Risk Management, Pfizer New York, New York
Sandra Cuellar Puri, Pharm.D., BCOP – Clinical Assistant Professor, University of Illinois Medical Center; Clinical Oncology Pharmacist, University Illinois at Chicago, Chicago, Illinois
Jeffrey Fudin, Pharm.D., DAAPM, FCCP – Clinical Pharmacy Specialist, Veteran Affairs Medical Center-Albany; Adjunct Associate Professor of Pharmacy Practice, Albany College of Pharmacy and Health Sciences, Albany, New York

PRN Business Meeting:

Our business meeting at the 2011 Annual Meeting will include an update on the status of BPS role delineation for pain and palliative care certification, a resident presentation on a select pain/palliative care topic, and an opportunity to network with colleagues. We invite and encourage all ACCP members with an interest in pain and palliative care to attend.

Agenda

6:00 p.m.–6:15 p.m.: Welcome/PRN Updates and Reports
6:15 p.m.–6:35 p.m.: BPS Role Delineation Study for Pain and Palliative Care Certification
6:35 p.m.–7:00 p.m.: Resident Presentation
7:00 p.m.–7:20 p.m.: Induction of New Officers/New Chair’s Address
7:20 p.m.–8:00 p.m.: Networking

Member News and Highlights:

Welcome to Our New Members!
Soha Adloni
Rebecca Bledsoe
Marc Cote
Sarah Eltaki
Chung Lu
Brianne Peroutka
Scott Preston
Sherilyn Van Osdol

Promotions
Michele L. Matthews, Pharm.D., CPE, was promoted to Associate Professor of Pharmacy Practice at the Massachusetts College of Pharmacy and Health Sciences, Boston, Massachusetts.

Accomplishments

Congratulations to the following PRN members who have successfully completed the requirements of the American Society of Pain Educators (ASPE) credentialing program and have been designated Certified Pain Educators (CPEs) since its inception in 2009:

Francine Farnsworth
Phyllis Anne Grauer
Thomas Gregory
Kathryn Hahn
Christopher Herndon
Cynthia Johnston
Karen F. Marlowe
Michele L. Matthews
Mary Lynn McPherson
Suzanne Nesbit
Ann Marie Rule
Kathryn Walker

Invited Presentations

Several of our PRN members were invited speakers at PAINWeek held in Las Vegas, Nevada, from September 7 to 10, 2011, and presented exceptional presentations on the following topics at this national multidisciplinary conference:

Christopher Herndon
Pain Therapeutics
A Topical Review of Pain Treatment

Mary Lynn McPherson
Acetaminophen: When to Use It and When to Say When
Developing Peer and Patient Education Materials
Assessment of Pain in Advanced Illness
Opioid Conversions
Pharmacologic Management of Pain in Advanced Illness
Methadone
Pharmacologic Management of CV, GU, GI, and Respiratory Symptoms in Patients with Advanced Illness
New Drugs in Pain Management and Palliative Care

Thomas Gregory
Chronic Pain Syndromes
Opioid Adverse Events: Beyond Constipation

Kathryn Hahn
Short-Acting and Long-Acting Opioids in the Treatment of Chronic, Episodic, and Breakthrough Pain
NSAIDs and Adjuvant Therapies for Chronic Pain Management

The Pharmacokinetics/Pharmacodynamics PRN is collaborating with the Pharmaceutical Industry PRN for a special session on pharmacometrics to be presented at the Annual Meeting in Pittsburgh. The session—titled “Pharmacometrics in Drug Development and Research”—will be held on Tuesday, October 18, from 1:15 p.m. to 3:15 p.m. in Convention Center Rooms 315 and 316. Speakers for the session represent academia, industry, and the FDA and include Joan M. Korth-Bradley, Nitin Mehrotra, and Paul R. Hutson.

Pharmaceutical Industry

The Pharmaceutical Industry has more than 240 members, which includes over 30 student members. The Pharmaceutical Industry PRN supports members working in the pharmaceutical industry and provides awareness and education to members who do not work in the industry. This year, the PRN focused on highlighting the accomplishments of its members and networking with other PRNs to foster collaboration on a variety of projects.

The PRN members are looking forward to meeting you at their networking forum on Monday, October 17, 2011, at the Annual Meeting. Please join us to catch up with old friends, meet new colleagues, and volunteer for upcoming PRN activities.

The PRN Programming Committee was successful this year in collaborating with several other PRNs to develop three interesting joint educational symposia for the ACCP Annual Meeting.

On Monday, October 17, from 1:30 p.m. to 3:30 p.m., our PRN, together with the Hematology/Oncology and Pain and Palliative Care PRNs, will host an educational focus session on “The Role of Clinical Pharmacists in Risk Evaluation and Mitigation Strategies (REMS) Programs.” Please support our PRN member, Joseph Heissler from Pfizer, who will be speaking during this session.
On Tuesday, October 18, from 10:15 a.m. to 11:45 a.m., the PRN, together with the Endocrine and Metabolism PRN, is hosting the educational symposia titled “Too Big, Too Small, Just Right: Dosing Issues in Obesity.” Come by and hear from our PRN member, Joan Korth-Bradley from Pfizer, who will be speaking during this session.
In addition, also on Tuesday, October 18, from 1:15 p.m. to 3:15 p.m., the PRN will collaborate with the Pharmacokinetics and Pharmacodynamics PRN to host the educational session titled “Pharmacometrics in Drug Development and Research.” Our PRN member, Joan Korth-Bradley from Pfizer, will be speaking during this session as well.

We would also like to thank Kay Uttech from Baxter for representing the PRN at the Career Roundtable session on Sunday, October 16, from 2:00 p.m. to 4:30 p.m.

The Nominations Committee was successful in developing a slate of candidates for the 2011–2012 PRN officers. Please welcome our new officers at the PRN networking forum:
Alicia Reese from Sanofi-Aventis as Chair
Rachel Couchenour from Chelsea Therapeutics as Chair-Elect
Sandra Chase from Otsuka America Pharmaceutical as Secretary/Treasurer

Thank you to the 2010–2011 PRN officers and committee members for making this a productive year.